Gene · 3675
ITGA3: integrin subunit alpha 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ITGA3: integrin subunit alpha 3. Genes, record 3675. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3675
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P26006 | Integrin alpha-3 | 1,051 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents80
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026516931 A | 2026-05-27 | 45 | P26006 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 49970 | P26006 | Espacenet |
| WO 2025259600 A2 | 2025-12-18 | 11 | P26006 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4581 | P26006 | Espacenet |
| EP 4611808 A1 | 2025-09-10 | 45 | P26006 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2135 | P26006 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2135 | P26006 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4581 | P26006 | Espacenet |
| US 12291562 B2 | 2025-05-06 | 71 | P26006 | Espacenet |
| US 12000003 B2 | 2024-06-04 | 24 | P26006 | Espacenet |
1 to 10 of 80
See all 80 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,647
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ITGA3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| R01DK069921 | The Laminin Receptors in Kidney Disease | 5 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 4 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| P30CA225520 | Stephenson Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| I01BX002025 | Molecular Mechanisms of Kidney Fibrosis | 3 | 2025 |
1 to 10 of 1,647Source NIH's project files
See all 1,647 nih grantsPapers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated reverse network toxicology and experimental validation identify PTP4A3 as a key target of Benzo[a]pyrene in prostate cancer. | Chem Biol Interact | 2026 | 42805285 | PubTator, text mining | PubMed |
| Functional alterations of peripheral blood-derived mesenchymal stem cells in erosive hand osteoarthritis: modulation by resveratrol. | Clin Exp Rheumatol | 2026 | 42752324 | PubTator, text mining | PubMed |
| Trio-Based Whole-Exome Sequencing Identifies Convergent Epithelial Junction-Related Pathways in Syndromic Hidradenitis Suppurativa. | Dermatology | 2026 | 42709635 | PubTator, text mining | PubMed |
| Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance. | Cancer Pathog Ther | 2026 | 42699527 | PubTator, text mining | PubMed |
| Biomimetic Hydrogels with Nucleus Pulposus-like Viscoelasticity and ECM Peptides for Discogenic Differentiation of Stem Cells. | ACS Biomater Sci Eng | 2026 | 42695568 | PubTator, text mining | PubMed |
| Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial-Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes. | Int J Mol Sci | 2026 | 42589604 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of ILNEB: Absence of classic dermatologic findings in a 12-year-old girl with homozygous ITGA3 p.Arg274Gln. | JAAD Case Rep | 2026 | 42569287 | PubTator, text mining | PubMed |
| Uncovering molecular and functional dynamics of human hematopoietic stem cells during in vitro culture for cell therapy manufacturing. | Cytotherapy | 2026 | 42556173 | PubTator, text mining | PubMed |
| A vesicular trafficking pathway mediated by N-ethylmaleimide-sensitive factor governs integrin maturation and podocyte integrity. | Kidney Int | 2026 | 42492856 | PubTator, text mining | PubMed |
| Oncogenic Gαq Signaling Remodels the Tumor Surfaceome and Rewires Intracellular Networks in Uveal Melanoma Models. | Cancers (Basel) | 2026 | 42352426 | PubTator, text mining | PubMed |
1 to 10 of 2,788
See all 2,788 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3675
GET https://conductscience.org/api/genes/v1/3675/patents?page=2